MANUFACTURING PRODUCTS
API AND ITS INTERMEDIATES
  ADAPALENE
ANAGRELIDE HCL
ANASTROZOLE
AZASETRON HCL
BICALUTAMIDE
DASATINIB
DOCETAXEL TRIHYDRATE
ENTECAVIR
EPLERENONE
ERLOTINIB
EZETIMIBE
GRANISETRON HCL
IBANDRONATE SODIUM
IMNATINIB MESYLATE
IRINOTECAM
IRSOGLADINE MALEATE
LAPATINIB
LERCANIDIPINE
LETROZOLE
LEVOSIMENDAN
LONIDAMINE
MONTELUKAST SODIUM
NOLATREXED 2HCL
PALONOSETRON HCL
PREGABLIN
RISEDRONATE SODIUM
RUBITECAM
SORAFENIB PARA TOLUENE SULFONATE
SUNITINIB MALATE
VATALANIB 2HCL
VORICONAZOLE
ZOLEDRONIC ACID
OTHERS
  AMIFOSTINE
CLADRIBINE
IRON SUCROSE
Pregna-4,9 (11)-Diene-7,21-Carboxylicacid,17-Hydroxy-3-Oxo-g-Lactone,Methyl ester(7a,17a)
Pregna-4,6,9(11)-triene-21-carboxylicacid,17-hdroxy-3-oxo-,g-lactone,(17a)-
 
TRADING PRODUCTS
 
 
  HOME ORDER CONTACT US  
 
  PRODUCTS
 

 API AND ITS INTERMEDIATES

ANAGRELIDE HCL
Therapeutic category: A treatment for Blood Cancer, to decrease the risk of blood clots
CAS NO.: 58579-51-4
Under development

1. 2,3-Dichloro-6-Nitro Benzonitrile
CAS NO.: 2112-22-3
Appearance: light yellow crystalline powder
Purity: 98%min
Production against firm order

2. 2-Aminomethyl-3,4-Dichloro Phenylamine
CAS NO.: 147249-42-1
Under development

3.  Ethyl (2-Cyanoimiao-5,6-Dichloro-1,2,3,4-tetrahydroquinazolin-3-yl) Acetate
Under development